Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/26/2025 | $38.00 | Neutral → Buy | Seaport Research Partners |
| 5/28/2025 | $23.00 | Hold | Truist |
| 3/5/2024 | $43.00 → $31.00 | Buy → Neutral | B. Riley Securities |
| 12/15/2023 | $43.00 | Buy | B. Riley Securities |
| 12/4/2023 | Buy → Neutral | Seaport Research Partners | |
| 3/28/2023 | $50.00 | Neutral → Buy | Seaport Research Partners |
| 8/30/2022 | Buy → Neutral | Seaport Research Partners | |
| 1/18/2022 | $72.00 | Buy | Seaport Research Partners |
4 - GENESCO INC (0000018498) (Issuer)
4 - GENESCO INC (0000018498) (Issuer)
4 - GENESCO INC (0000018498) (Issuer)
8-K - GENESCO INC (0000018498) (Filer)
8-K - GENESCO INC (0000018498) (Filer)
8-K - GENESCO INC (0000018498) (Filer)
4 - GENESCO INC (0000018498) (Issuer)
Seaport Research Partners upgraded Genesco from Neutral to Buy and set a new price target of $38.00
Truist initiated coverage of Genesco with a rating of Hold and set a new price target of $23.00
B. Riley Securities downgraded Genesco from Buy to Neutral and set a new price target of $31.00 from $43.00 previously
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum
Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the fourth quarter fiscal 2026 on March 6, 2026, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the fourth quarter fiscal 2026 results will be available on the Genesco website on March 6, 2026 at https://www.genesco.com/investor-relations/investor-o
Genesco Inc. (NYSE:GCO) today announced that Cassandra "Sandra" Harris, Chief Financial Officer, is stepping down from her role effective March 6, 2026, to pursue other opportunities. Harris will assist with an orderly transition, participate in Genesco's fourth quarter and fiscal year 2026 earnings conference call in early March and will continue to support the Company as a consultant and principal accounting officer through the filing of the Company's fiscal year 2026 Form 10-K on March 25, 2026. The Company has initiated an active search for a permanent Chief Financial Officer and is moving expeditiously to identify a strategic leader to continue driving shareholder value. Effective
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum
--A Proven Executive with Deep Retail Expertise and Experience Implementing Human Resources Transformation-- Genesco Inc. (NYSE:GCO) today announced that Kyle Polischuk has been named Chief Human Resources Officer, leading the enterprise wide human resources function for the footwear focused lifestyle retailer and branded company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250107024161/en/Kyle Polischuk , Genesco Chief Human Resources Officer (Photo: Business Wire) "Kyle's strategic leadership and exceptional track record building dynamic organizations, developing talent, and promoting strong cultures will make a tremendou
--A proven CFO, finance leader and seasoned global retail and consumer brands executive, Harris adds significantly to Genesco's deep leadership bench-- Genesco Inc. (NYSE:GCO), after a broad search process, today announced the appointment of Cassandra "Sandra" Harris as Senior Vice President, Finance and Chief Financial Officer, effective October 7, 2024. Harris succeeds Thomas A. George, whose planned retirement will take effect on December 12, 2024 to ensure an orderly transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240930244006/en/Cassandra "Sandra" Harris, Genesco Senior Vice President, Finance and Chief Financial
SC 13G - GENESCO INC (0000018498) (Subject)
SC 13G/A - GENESCO INC (0000018498) (Subject)
SC 13G/A - GENESCO INC (0000018498) (Subject)
Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the fourth quarter fiscal 2026 on March 6, 2026, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the fourth quarter fiscal 2026 results will be available on the Genesco website on March 6, 2026 at https://www.genesco.com/investor-relations/investor-o
Genesco Inc. (NYSE:GCO) today announced that Cassandra "Sandra" Harris, Chief Financial Officer, is stepping down from her role effective March 6, 2026, to pursue other opportunities. Harris will assist with an orderly transition, participate in Genesco's fourth quarter and fiscal year 2026 earnings conference call in early March and will continue to support the Company as a consultant and principal accounting officer through the filing of the Company's fiscal year 2026 Form 10-K on March 25, 2026. The Company has initiated an active search for a permanent Chief Financial Officer and is moving expeditiously to identify a strategic leader to continue driving shareholder value. Effective
Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the third quarter fiscal 2026 on December 4, 2025, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the third quarter fiscal 2026 results will be available on the Genesco website on December 4, 2025 at https://www.genesco.com/investor-relations/invest